June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
Topical Linezolid 0.2% for the Treatment of Gram Positive Bacterial Keratitis
Author Affiliations & Notes
  • Elmer Tu
    Ophthalmology, University of Illinois at Chicago, Glenview, IL
  • Sandeep Jain
    Ophthalmology, University of Illinois at Chicago, Glenview, IL
  • Footnotes
    Commercial Relationships Elmer Tu, None; Sandeep Jain, PCT/US20/51562 (P)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2899. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Elmer Tu, Sandeep Jain; Topical Linezolid 0.2% for the Treatment of Gram Positive Bacterial Keratitis. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2899.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: To report the clinical efficacy of topical linezolid for the treatment of vancomycin-resistant of -intolerant gram positive keratitis.

Methods: All cases of bacterial keratitis treated at the University of Illinois Eye and Ear Infirmary 2007 to date with topical linezolid were identified from the Cornea and External Disease Clinic and were reviewed for culture results, prior therapy, clinical course and visual outcome.

Results: Three cases of gram positive keratitis were identified that were treated with topical linezolid. Cases consisted of one case of recalcitrant Vancomycin Resistant Enterococcus faecalis (VRE) and two cases of infectious crystalline keratitis, one culture positive for an uncharacterized Staphylococcus and the other for Streptococcus mitis. All three patients had rapid resolution of their primary gram positive keratitis and noted no pain associated with topical therapy, but the VRE keratitis developed a new Candida keratitis elsewhere in the same cornea at the end of therapy.

Conclusions: Topical linezolid 0.2% can be an effective compounded antibiotic for the treatment of gram positive keratitis, including VRE, and is both significantly more comfortable and less immediately toxic to the ocular surface than topical vancomycin.

Keywords: 573 keratitis • 422 antibiotics/antifungals/antiparasitics • 433 bacterial disease  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.